TrialSpark Stock
TrialSpark is a technology company that helps bring treatments to patients faster by reimagining how clinical trials are run.
Sign up today and learn more about TrialSpark Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About TrialSpark Stock
Investors
Sequoia Capital
Market Kurly, Robinhood, Airbnb, Instacart, Tokopedia, Stripe, DoorDash, Rappi, CoinSwitch Kuber, UiPath
Felicis Ventures
Wish, Scopely, Opendoor, Dollar Shave Club, Gusto, Zipline, Coalition, Plaid, Crusoe Energy Systems, Guild Education
Thrive Capital
Instacart, Stripe, Compass, Airtable, Opendoor, Nubank, Slack, Oscar Health, Unity Technologies, Cityblock Health
Management
CEO and Co-Founder
Benjamine Liu
CTO and Co-Founder
Linhao Zhang
Advisor
Bobby Guelich
Director of Technical Operations
Russell Fowles
Chief People Officer
Melissa Kaplan Enbar
Chief Medical Officer
Ken Somberg
Press
biospace - Nov, 29 2022
TrialSpark announces acquisition of a clinical-stage immunodermatology portfolio and formation of Libertas Biobiospace - Oct, 9 2022
TrialSpark and Sanofi Ink Six-Drug Deal Targeting Areas with High Unmet Needfiercebiotech - Oct, 6 2022
Sanofi inks deal with TrialSpark to find, license new drugsbiospace - Oct, 5 2022
TrialSpark announces partnership with major pharmaceutical company to jointly acquire and develop clinical-stage novel therapiestrib - Aug, 11 2022
Immigrant Ben Liu And TrialSpark Revolutionizing Clinical Trials